Casandra
Casandra Test Code QD82711Version 1 (DRAFT)
Performing Lab
Lab Quest DiagnosticsLab Test ID 39422
Drug Monitoring, Panel 1, with Confirmation, Urine
Also known as: Prescription Drug Monitoring, Pain Management
Clinical Use
Order TestUse
This is a comprehensive urine drug monitoring panel that screens multiple commonly abused drugs and related metabolites, with any non-negative results reflexing to confirmatory testing, improving accuracy and reducing false positives. It is useful in clinical, workplace, or patient-monitoring settings.
Special Instructions
Not provided.
Limitations
Not provided.
Test Details
Methodology
Other
Biomarkers
7 targets
Abnormal Specimen Validity TestAlphahydroxyalprazolamAlphahydroxymidazolamAlphahydroxytriazolamAminoclonazepamAmobarbitalAmphetamines
Result Turnaround Time
2-3 days
Related Documents
For more information, please review the documents below
Specimen Requirements
Specimen
Urine
Volume
Not provided
Minimum Volume
Not provided
Related Tests
Other tests from different labs that may be relevant
Drug Panel 7, Urine - Screen with Reflex to Confirmation/Quantitation
ARUP Laboratories
Drug Panel 7A, Urine - Screen with Reflex to Confirmation/Quantitation
ARUP Laboratories
Drug Panel 9A, Urine - Screen with Reflex to Confirmation/Quantitation
ARUP Laboratories
Drug Abuse Survey with Confirmation, Panel 9, Random, Urine
Mayo Clinic Lab
Drug Screen 17 With Reflex Confirmation (Pregnancy Profile; ETG, AMP, BAR, BZO, COC, PCP, THC, 6AM, OPI, OXY, TAP, MD, FEN, BUP, PPX, TRAM, NIC), Urine
Labcorp
Comprehensive Drug Profile, urine
Labcorp
Drug Profile, Screen with Reflex to Quantitation
ARUP Laboratories